Popular Articles

PARI Pharma's Nebulized DSCG Shows Results Similar To Inhaled Steroids In Asthma Studies Presented At ATS
This week, Swiss researchers presented positive data from an ongoing Phase II clinical study at the American Thoracic Society (ATS) International Conference that compared PARI Pharma"s inhaled IsoCrom, an isotonic 1% disodium cromoglycate (DSCG) solution, to inhaled corticosteroids (ICS) in 28 children with atopic asthma. Results showed decreases in mean asthma symptom scores without a change in lung function for both groups. These results were achieved with IsoCrom administered via a customized small droplet Investigational eFlow Nebulizer System designed to deliver drugs to the deep lungs. One of the benefits of DSCG is the long track record as an extremely safe drug.

Cancer Risk In Delaying Sex Assignment Surgery
An editorial and a case report on Disorders of Sexual Development (DSD) in the Medical Journal of Australia highlight the need for early diagnosis and effective risk management in these rare but potentially life threatening cases.
News of the day
Terminally Ill Patients And Their Physicians Delay Conversations About End-of-Life Choices, Study Finds
About half of terminally ill patients do not have discussions with their physicians regarding end-of-life choices, according to a Harvard Medical School study published in the Archives of Internal Medicine, the Boston Globe reports.The study, funded by the National Cancer Institute, examined files on 1,517 patients in California, Iowa and Alabama with metastasized lung cancer. According to the Globe, a majority of patients diagnosed with metastasized lung cancer do not survive two years. Researchers asked the patients whether a physician or other health care provider had recommended hospice care or discussed end-of-life care preferences with them. According to the study, about 49% of blacks and 43% of Hispanics had discussed end-of-life care preferences with a physician or health care provider within four to seven months of their diagnosis, compared with 53% of whites and 57% of Asians. Lead study author Haiden Huskamp, an associate professor at Harvard Medical School, said, "Patients who had unrealistic expectations about how long they had to live were much less likely to talk about hospice with their doctor." Huskamp theorized that patients who said they did not discuss end-of-life options with providers might not have completely understood their prognosis or chose to believe in a better outcome. Huskamp also said physicians typically are not well-trained to handle some delicate conversations (Lazar, Boston Globe, 5/26).
Sexual Health

U.K. City To Participate In Pilot Home-Based HIV Testing Program

The United Kingdom government has selected the city of Sheffield to participate in a three-month pilot program aimed at increasing HIV detection rates by offering home-based test kits, the Sheffield Star reports. The initiative, which will target men who have sex with men, will allow people to obtain the test kits through Web sites or community outreach centers. To take the HIV test, individuals must take a mouth swab and send it to a laboratory for testing. The lab then confidentially notifies the individual of the test results with a call or text message, Steve Slack, director of Sheffield"s Centre for HIV and Sexual Health, said. The city aims to launch the program in June. According to the Star, Sheffield is the only city in the northern part of the country to be included in the pilot program.Nearly one-third of HIV-positive U.K. residents are unaware of their status and therefore not accessing early treatment, the Star reports. Slack said the pilot program will be "an unrivalled way to engage with hard-to-reach communities to encourage more people to come forward for testing." He added that the "great thing" about home-based testing is its "ease" and that it is "completely confidential." Christine Bowman, consultant physician at Sheffield Teaching Hospitals, said, "HIV testing is not something people should be afraid to come forward for." She added, "Thousands of people in the U.K. are tested each year, but we would like to test more" (Lahive, Sheffield Star, 5/21). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):